Cell sheet trial for esophageal cancer patients ends early with just one volunteer
NCT ID NCT04689594
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a treatment using a sheet of the patient's own mouth cells to prevent the esophagus from narrowing after cancer removal surgery. Only one person took part before the study was stopped early. The goal was to see if the cell sheet could safely reduce scarring and keep the esophagus open.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Human (autologous) oral mucosal cell sheet
- What this could lead to
- If it works, this could offer a way to prevent esophageal narrowing after cancer surgery, reducing the need for repeated procedures.
- What could go wrong
- The trial was terminated early with only 1 participant, so results are very limited. It is unclear if the treatment is effective or safe in a larger group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPERFICIAL ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Okayama University Hospital
Okayama, 700-8558, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.